Serum Levels of Type II Secretory Phospholipase A2 and the Risk of Future Coronary Artery Disease in Apparently Healthy Men and Women-Reference-Cited by-同舟云学术

Serum Levels of Type II Secretory Phospholipase A2 and the Risk of Future Coronary Artery Disease in Apparently Healthy Men and Women

Published:2005-04 Issue:4 Volume:25 Page:839-846
ISSN:1079-5642
Container-title:Arteriosclerosis, Thrombosis, and Vascular Biology
language:en
Short-container-title:ATVB

Author:

Boekholdt S. Matthijs¹,Keller Tymen T.¹,Wareham Nicholas J.¹,Luben Robert¹,Bingham Sheila A.¹,Day Nicholas E.¹,Sandhu Manjinder S.¹,Jukema J. Wouter¹,Kastelein John J.P.¹,Hack C. Erik¹,Khaw Kay-Tee¹

Affiliation:

1. From the Departments of Cardiology (S.M.B.) and Vascular Medicine (T.T.K., J.J.P.K.), Academic Medical Center, Amsterdam, The Netherlands; Medical Research Council Epidemiology Unit (N.J.W.), Cambridge, the Department of Public Health and Primary Care (R.L., N.E.D., M.S.S., K.T.K.), Institute of Public Health, University of Cambridge, and the Medical Research Council Dunn Nutrition Unit (S.A.B.), Cambridge, United Kingdom; and the Department of Cardiology (J.W.J.), Leiden University Medical Center,...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference46 articles.

1. Inflammation in atherosclerosis

2. Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men

3. C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women

4. Arteriosclerosis, Thrombosis, and Vascular Biology , 2004

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methylglyoxal in Cardiometabolic Disorders: Routes Leading to Pathology Counterbalanced by Treatment Strategies;Molecules;2023-11-24

2. Phospholipase A2 enzymes differently impact PUFA release and oxylipin formation ex vivo in rat hearts;Prostaglandins, Leukotrienes and Essential Fatty Acids;2023-04

3. Endocrine regulation of phospholipase as a therapeutic target for cardiovascular diseases;Phospholipases in Physiology and Pathology;2023

4. Angiopoietins, vascular endothelial growth factors and secretory phospholipase A2 in heart failure patients with preserved ejection fraction;European Journal of Internal Medicine;2022-12

5. Association between serum secretory phospholipase A2 and risk of ischaemic stroke;European Journal of Neurology;2021-07-30